Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies

Table 3 Second-line eradication rates of Helicobacter pylori

	Achieved/analyzed patients (n)	Eradication rate (95%CI)	P value1
Per protocol			0.351
PAC (n = 31)	27/31	87.1% (75.3-98.9)
PAM (n = 24)	22/24	91.7% (80.6-100)
Sequential (n = 25)	20/25	80.0% (64.3-95.9)
Concomitant (n = 10)	7/10	70.0% (34.8-93.3)
Intent-to-treat			0.657
PAC (n = 36)	27/36	75.0% (60.9-89.1)
PAM (n = 27)	22/27	81.5% (66.8-96.1)
Sequential (n = 25)	20/25	80.0% (64.3-95.9)
Concomitant (n = 11)	7/11	63.6% (35.2-92.1)

¹P-value of χ² test. PAC: Rabeprazole, amoxicillin and clarithromycin; PAM: Rabeprazole, amoxicillin and metronidazole.